Clinical Trial Update: Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating MK-1029 for persistent asthma not controlled with montelukast; completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MK-1029

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2018-11-23